Pharmas Join To Build Inflammation Biomarkers In Alzheimer's, Depression

 
• By Emily Hayes

Drug firms exploring link between inflammation and central nervous system disorders are now sharing resources through public/private Biomarkers Consortium project.

Brain decline and dementia or aging as memory loss concept for brain cancer decay or an Alzheimer's disease with old rusting mechanical gears and cog wheels in the shape of a human head with rust.

More from Clinical Trials

More from R&D